tradingkey.logo
Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Korro Bio Inc

KRRO

15.300USD

+1.450+10.47%
Market hours （ET）Quotes delayed by 15 min
143.65MMarket Cap
LossP/E TTM

Korro Bio Inc

15.300

+1.450+10.47%
OverviewCompanyFinancials
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total revenue
--2.55M
--2.27M
----
----
----
Revenue
--2.55M
--2.27M
----
----
----
Operating expenses
28.51%27.57M
--25.31M
--23.29M
--24.13M
--21.45M
R&D expenses
45.44%19.74M
--16.96M
--15.96M
--17.14M
--13.57M
Depreciation, depletion, and amortization
68.73%1.23M
--1.30M
--900.00K
--721.00K
--726.00K
Operating profit
-16.63%-25.02M
---23.04M
---23.29M
---24.13M
---21.45M
Net non-operating interest income (expenses)
Other non-operating income (expenses)
-14.64%1.63M
--1.94M
--2.28M
--2.33M
--1.91M
Income before tax
-19.69%-23.39M
---21.10M
---21.01M
---21.80M
---19.54M
Income tax
-100.00%0.00
--103.00K
---9.00K
--30.00K
--17.00K
Income after tax
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income from continuous operations
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income attributable to controlling interests
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Net income attributable to common shareholders
-19.58%-23.39M
---21.20M
---21.00M
---21.83M
---19.56M
Basic earnings per share
-2.19%-2.49
---2.26
---2.26
---2.43
---2.44
Diluted earnings per share
-2.19%-2.49
---2.26
---2.26
---2.43
---2.44
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
KeyAI